Danaher Raises €2.98 Billion in Euro-Denominated Senior Notes to Fund Masimo Acquisition

Event summary

  • Danaher priced €2.98 billion in euro-denominated senior notes due between 2028 and 2038.
  • Proceeds will partially fund the acquisition of Masimo Corporation and cover related costs.
  • Notes include floating-rate and fixed-rate offerings with varying maturities and yields.
  • Offering expected to close on April 29, 2026, subject to customary closing conditions.

The big picture

Danaher's €2.98 billion debt offering underscores its commitment to the Masimo acquisition, a strategic move to bolster its life sciences and diagnostics portfolio. The financing reflects broader trends in the healthcare sector, where consolidation is accelerating to drive innovation and cost efficiencies. The scale of the offering highlights Danaher's aggressive growth strategy, but also raises questions about its ability to manage increased leverage.

What we're watching

Integration Challenges
How Danaher will integrate Masimo's operations and technologies into its existing portfolio.
Debt Management
Whether Danaher can sustain its debt levels while maintaining financial flexibility.
Market Reactions
The pace at which investors respond to the acquisition and debt financing.

Related topics

Diagnostics